The American Diabetes Association and Xeris Pharmaceuticals Announce National Collaboration to Provide Life-Saving Hypoglycemia Education and Awareness
Portfolio Pulse from
The American Diabetes Association and Xeris Pharmaceuticals have announced a multi-year strategic partnership to promote awareness and education on the importance of glucagon for individuals with diabetes at risk of hypoglycemia.
January 21, 2025 | 2:15 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Xeris Pharmaceuticals has entered a strategic partnership with the American Diabetes Association to promote glucagon awareness for diabetes patients, aligning with ADA's updated care standards.
The partnership with the ADA is likely to enhance Xeris Pharmaceuticals' visibility and credibility in the diabetes care market. This collaboration aligns with ADA's updated care standards, potentially increasing demand for Xeris's glucagon products, which could positively impact their stock price.
CONFIDENCE 95
IMPORTANCE 80
RELEVANCE 90